TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95)

Immunity

Volumn 6, Issue 1, 1997, Pages 79-88

  Bodmer, Jean Luc ^d   Burns, Kim ^d   Schneider, Pascal ^d   Hofmann, Kay ^a   Steiner, Véronique ^d   Thome, Margot ^d   Bornand, Thierry ^d   Hahne, Michael ^d   Schröter, Michael ^d   Becker, Karin ^d   Wilson, Anne ^d   French, Lars E ^b   Browning, Jeffrey L ^c   Macdonald, H Robson ^d   Tschopp, Jürg ^b  

^a SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c BIOGEN   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CELL LINE; GENE MAPPING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOLECULAR CLONING; PRIORITY JOURNAL; THYMOCYTE;

EID: 0030896087     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80244-7     Document Type: Article

References (50)

1. Banner, D.W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, HJ., Broger, C., Loetscher, H., and Lesslauer, W. (1993). Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: implications for TNF receptor activation. Cell 73, 431-445.
2. Boldin, M.P., Mett, I.L., Varfolomeev, E.E., Chumakov, I., Shemeravni, Y., Camonis, J.H., and Wallach, D. (1995a). Self-association of the death domains of the p55 tumor necrosis factor (TNF) receptor and Fas/Apo1 prompts signaling for TNF and Fas/Apo1 effects. J. Biol. Chem. 270, 387-391.
3. Boldin, M.P., Varfolomeev, E.E., Pancer,C., Mett, I.L, Camonis, J.H., and Wallach, D. (1995b). A novel protein that interacts with the death domain of Fas/Apo1 contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798.
4. Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., and Wallach, D. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 85, 803-815.
5. Bordier, C. (1981). Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256, 1604-1607.
6. Borner, C., Martinou, l., Mattmann, C., Irmler, M., Schaerer, E., Martinou, J.C., and Tschopp, J. (1994). The protein bcl-2 α does not require membrane attachment, but two conserved domains to suppress apoptosis. J. Cell Biol. 126, 1059-1068.
7. Browning, J.L, Ngam-ek, A., Lawton, P., DeMarinis, J., Tizard, R., Chow, E.P., Hession, C., O'Brine-Greco, B., Foley, S.F., and Ware, C.F. (1993). Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72, 847-856.
8. Browning, J.L, Miatkowski, K., Griffiths, D.A., Bourdon, P.R., Hession, C., Ambrose, C.M., and Meier, W. (1996). Preparation and characterization of soluble recombinant heterotrimeric complexes of human lymphotoxins α and β. J. Biol. Chem. 271, 8618-8626.
9. Bucher, P., Karplus, K., Moeri, N., and Hofmann, K. (1996). A flexible search technique based on generalized profiles. Comput. Chem. 20, 3-24.
10. Byrn, R.A., Mordenti, J., Lucas, C., Smith, D., Marsters, S.A., Johnson, J.S., Cossum, P., Chamow, S.M., Wurm, F.M., Gregory, T., et al. (1990). Biological properties of a CD4 immunoadhesin. Nature 344, 667-670.
11. Chinnaiyan, A.M., Orourke, K., Tewari, M., and Dixit, V.M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 87, 505-512.
12. Crowe, P.D., Van Arsdale, T.L., Walter, B.N., Ware, C.F., Hession, C., Ehrenfels, B., Browning, J.L, Din, W.S., Goodwin, R.G., and Smith, C.A. (1994). A lymphotoxin-β-specific receptor. Science 264, 707-710.
13. Dixit, V.M. (1996). The cell-death machine. Curr. Biol. 6, 555-562.
14. Feinstein, E., Kimchi, A., Wallach, D., Boldin, M., and Varfolomeev, E. (1995). The death domain: a module shared by proteins with diverse cellular functions. Trends Biochem. Sci. 20, 342-344.
15. Fernandesalnemri, T., Armstrong, R.C., Krebs, J., Srinivasula, S.M., Wang, L., Bullrich, F., Fritz, L.C., Trapani, J.A., Tomaselli, K.J., Litwack, G., and Alnemri, E.S. (1996). In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA 93, 7464-7469.
16. Francis, M.J., Hastings, G.Z., Brown, F., McDermed, J., Lu, Y.A., and Tam, J.P. (1991). Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of footand-mouth disease virus. Immunology 73, 249-254.
17. Fuchs, P., Strehl, S., Dworzak, M., Himmler, A., and Ambras, P.F. (1992). Structure of the human TNF receptor 1 (p60) gene (TNFR1) and localization to chromosome 12p13. Genomics 13, 219-224. Erratum: Genomics 13, 1384.
18. Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L.E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., Cerottini, J.-C., and Tschopp, J. (1996). Melanoma cells express Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 274, 1363-1366.
19. Hawkins, C.J., and Vaux, D.L. (1994). Analysis of the role of bcl-2 in apoptosis. Immunol. Rev. 142, 127-139.
20. Heng, H., and Tsui, L. (1993). Modes of DAPI banding and simultaneous in situ hybridization. Chromosoma 102, 325-332.
21. Henkart, P.A. (1996). ICE family proteases: mediators of all apoptotic cell death? Immunity 4, 195-201.
22. Hofmann, K., and Tschopp, J. (1995). The death domain motif found in Fas (Apo-1) and TNF receptor is present in proteins involved in apoptosis and axonal guidance. FEBS Lett. 371, 321-323.
23. Hsu, H., Xiong, J., and Goeddel, D.V. (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81, 495-504.
24. Itoh, N., and Nagata, S. (1993). A novel protein domain required for apoptosis: mutational analysis of human Fas antigen. J. Biol. Chem. 268, 10932-10937.
25. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-l., Sameshima, M., Hase, A., Seto, Y., and Nagata, S. (1991). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
26. Korsmeyer, S.J. (1995). Regulators of cell death. Trends Genet. 11, 101-105.
27. Krammer, P.H., Dhein, J., Walczak, H., Behrmann, I., Mariani, S., Matiba, B., Fath, M., Daniel, P.T., Knipping, E., Westendorp, M.O., et al. (1994). The role of APO-1 -mediated apoptosis in the immune system. Immunol. Rev. 42, 175-191.
28. Kumar, S. (1995). ICE-like proteases in apoptosis. Trends Biochem. Sci. 20, 198-202.
29. Loetscher, H., Pan, Y.C., Lahm, H.W., Gentz, R., Brockhaus, M., Tabuchi, H., and Lesslauer, W. (1990). Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61, 351-359.
30. Los, M., Van de Craen, M., Penning, L.C., Schenk, H., Westendorp, M., Baeuerle, P.A., Droge, W., Krammer, P.H., Fiers, W., and Schulze-Osthoff, K. (1995). Requirement of an ICE/CED-3 proteasefor Fas/ APO-1-mediated apoptosis. Nature 375, 81-83.
31. Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., Mann, M., Krammer, P.H., Peter, M.E., and Dixit, V.M. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817-827.
32. Nagata, S. (1994). Mutations in the Fas antigen gene in Ipr mice. Semin. Immunol. 6, 3-8.
33. Nagata, S., and Golstein, P. (1995). The Fas death factor. Science 267, 1449-1456.
34. Peitsch, M.C., Polzar, B., Stephan, H., Crompton, T., MacDonald, H.R., Mannherz, H.G., and Tschopp, J. (1993). Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J. 12, 371-377.
35. Pitti, R.M., Marsters, S.A., Ruppert, S., Donahue, C.J., Moore, A., and Ashkenazi, A. (1996). Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271, 12687-12690.
36. Russell, J.H. (1983). Internal disintegration model of cytotoxic lymphocyte-induced target damage. Immunol. Rev. 72, 97-118.
37. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual (Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press).
38. Schroter, M., Lowin, B., Borner, C., and Tschopp, J. (1995). Regulation of fas(apo-1/cd95)-and perforin-mediated lytic pathways of primary cytotoxic T lymphocytes by the protooncogene bcl-2. Eur. J. Immunol. 25, 3509-3513.
39. Smith, C.A., Davis, T., Wignall, J.M., Din, W.S., Farrah, T., Upton, C., McFadden, G.,and Goodwin, R.G. (1991 ).T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem. Biophys. Res. Commun. 176, 335-342.
40. Smith, C.A., Farrah, T., and Goodwin, R.G. (1994). The TNF receptor super-family of cellular and viral proteins: activation, costimulation, and death. Cell 76, 959-962.
41. Strasser, A., Harris, A.W., Huang, D.C.S., Krammer, P.M., and Cory, S. (1995). Bcl-2 and Fas/Apo-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14, 6136-6147.
42. Tartaglia, LA.,Rothe, M., Hu, Y.F.,and Goeddel, D.V.(1993a). Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 73, 213-216.
43. Tartaglia, LA., Ayres, T.M., Wong, G.H., and Goeddel, D.V. (1993b). A novel domain within the 55 kd TNF receptor signals cell death. Cell 74, 845-853.
44. Tewari, M., and Dixit, V.M. (1995). Fas-and tumor necrosis factorinduced apoptosis is inhibited by the poxvirus CrmA gene product. J. Biol. Chem. 270, 3255-3260.
45. Upton, C., Macen, J.L, Schreiber, M., and McFadden, G. (1991). Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184, 370-382.
46. Ware, C.F., Vanarsdale, S., and Vanarsdale, T.L. (1996). Apoptosis mediated by the TNF-related cytokine and receptor families. J. Cell. Biochem. 60, 47-55.
47. Watanabe, F.R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., and Nagata, S. (1992a). Lymphoproliferation disorder in mice explained by defect in Fas antigen that mediates apoptosis. Nature 356, 314-317.
48. Watanabe, F.R., Brannan, C.I., Itoh, N., Yonehara, S., Copeland, N.G., Jenkins, N.A., and Nagata, S. (1992b). The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274-1279.
49. Wiley, S.R., Schooley, K., Smolak, P.J., Din, W.S., Huang, C.P., Nicholl, U.K., Sutherland, G.R., Smith, T.D., Rauch, C., Smith, C.A., and Goodwin, R.G. (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673-682.
50. Wilson, A., de Villartay, J.P., and MacDonald, H.R. (1996). T cell receptor δ gene rearrangement and T early α (TEA) expression in immature αβ lineage thymocytes: implications for αβ/-γδ lineage commitment. Immunity 4, 37-45.